aspect
of
atenolol)
→
ReceivesAction
→
maintained in long-term follow-up studies
Typicality: | 0.250 |
Saliency: | 0.000 |
without placebo control | 3 | other |
effect → be maintained in → long-term follow-up studies | 3 |
negative | neutral | positive |
0.007 | 0.760 | 0.233 |
Raw frequency | 3 |
Normalized frequency | 0.000 |
Modifier score | 0.500 |
Perplexity | 34.111 |